Search for: "Paradox Holdings, Inc." Results 1 - 20 of 89
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Apr 2024, 9:05 pm by renholding
For many business economists and legal academics, the purpose of any business organization is simply stated: to maximize profits. [read post]
14 Mar 2024, 6:56 am by centerforartlaw
Further, as a limited-edition art object, the handbag holds value beyond its material components. [read post]
18 Oct 2023, 1:52 pm by Sasha Volokh
[Serial-blogging my recent article in the Journal of Free Speech Law] Previously, I blogged the abstract, introduction, Part I, and Part II of my new article, Taxing Nudity: Discriminatory Taxes, Secondary Effects, and Tiers of Scrutiny, which has just been published in the Journal of Free Speech Law. [read post]
19 Jul 2023, 1:30 pm by Satya Marar
In her 2018 paper, Amazon’s Antitrust Paradox, she summarizes the leverage and foreclosure arguments against vertical integration as follows: Leverage reflects the idea that a firm can use its dominance in one line of business to establish dominance in another. [read post]
8 Jul 2023, 4:33 pm by Barry Barnett
The burdens of post-Paradox jurisprudence remain firmly in place. [read post]
21 Jun 2023, 7:20 am by Terry Hart
It was central to the Court’s holding in its previous transformative use decision, Campbell v. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
In this part, I take a much deeper dive into the economic literature to determine whether the FTC’s theory of harm is likely to hold up in court and whether the commission has picked the right forum in which to bring its claims. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
In this part, I take a much deeper dive into the economic literature to determine whether the FTC’s theory of harm is likely to hold up in court and whether the commission has picked the right forum in which to bring its claims. [read post]
6 Feb 2023, 10:09 am by Dennis Crouch
Sunovion Pharms., Inc., 715 F.3d 1351 (Fed. [read post]
29 Nov 2021, 10:17 am by Bailey Waltzer
If the promise of their product is wrong, it leads to a higher rate of PAH than expected; Zeltiq Aesthetics Inc. and Allergan should be made to pay. [read post]